GSK-3β: A bifunctional role in cell death pathways

International Journal of Cell Biology

Volumn , Issue , 2012, Pages

  Jacobs, Keith M ^a   Bhave, Sandeep R ^b   Ferraro, Daniel J ^a   Jaboin, Jerry J ^a,c   Hallahan, Dennis E ^a,c,d   Thotala, Dinesh ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c USA   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; 2 (3 CHLORO 4 HYDROXYANILINO) 3 (2 NITROPHENYL)MALEIMIDE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; 6 ARYL PYRAZOLE [3,4 B]PYRIDINE 4; ABC TRANSPORTER; BERYLLIUM; CELECOXIB; CERAMIDE; CURCUMIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEATH RECEPTOR; DIFFERENTIATION INDUCING FACTOR; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK TRANSCRIPTION FACTOR 1; INDIRUBIN; LIPOPOLYSACCHARIDE; LITHIUM; MAGNESIUM ION; PAULLONE DERIVATIVE; PEPTIDE; PROTEIN KINASE B INHIBITOR; PSEUDOSUBSTRATE PEPTIDE; RAPAMYCIN; RETINOID; STAUROSPORINE; TRICHOSTATIN A; UNCLASSIFIED DRUG; WORTMANNIN;

ALZHEIMER DISEASE; APOPTOSIS; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CHEMOTHERAPY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DNA DAMAGE; DRUG MECHANISM; DRUG TARGETING; ENDOPLASMIC RETICULUM STRESS; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; GLIOBLASTOMA; GLUCOSE METABOLISM; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOXIA; IC 50; IMMUNE SYSTEM; INFLAMMATION; ISCHEMIA; MOLECULAR BIOLOGY; NEOPLASM; NERVE CELL LESION; NEUROTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIATION INJURY; REGULATORY MECHANISM; REVIEW; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

EID: 84862276453     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2012/930710     Document Type: Review

References (135)

1. Frame S., Cohen P., GSK3 takes centre stage more than 20 years after its discovery Biochemical Journal 2001 359 1 1 16 (Pubitemid 32939202)
2. Doble B. W., Woodgett J. R., GSK-3: tricks of the trade for a multi-tasking kinase Journal of Cell Science 2003 116 7 1175 1186 (Pubitemid 36410657)
3. Jope R. S., Johnson G. V. W., The glamour and gloom of glycogen synthase kinase-3 Trends in Biochemical Sciences 2004 29 2 95 102 (Pubitemid 38186580)
4. Grimes C. A., Jope R. S., The multifaceted roles of glycogen synthase kinase 3 in cellular signaling Progress in Neurobiology 2001 65 4 391 426 (Pubitemid 32781670)
5. Luo J., Glycogen synthase kinase 3 (GSK3 ) in tumorigenesis and cancer chemotherapy Cancer Letters 2009 273 2 194 200
6. Pap M., Cooper G. M., Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3 signaling pathway Molecular and Cellular Biology 2002 22 2 578 586 (Pubitemid 34027502)
7. Sanchez J. F., Sniderhan L. F., Williamson A. L., Fan S., Chakraborty-Sett S., Maggirwar S. B., Glycogen synthase kinase 3 -mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor B signaling Molecular and Cellular Biology 2003 23 13 4649 4662 (Pubitemid 36734753)
8. Cohen P., Frame S., The renaissance of GSK3 Nature Reviews Molecular Cell Biology 2001 2 10 769 776 (Pubitemid 33679839)
9. Yazlovitskaya E. M., Edwards E., Thotala D., Fu A., Osusky K. L., Whetsell W. O., Boone B., Shinohara E. T., Hallahan D. E., Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation Cancer Research 2006 66 23 11179 11186 (Pubitemid 46009945)
10. Ter Haar E., Coll J. T., Austen D. A., Hsiao H. M., Swenson L., Jain J., Structure of GSK3 reveals a primed phosphorylation mechanism Nature Structural Biology 2001 8 7 593 596 (Pubitemid 32613006)
11. Dajani R., Fraser E., Roe S. M., Young N., Good V., Dale T. C., Pearl L. H., Crystal structure of glycogen synthase kinase 3 : structural basis for phosphate-primed substrate specificity and autoinhibition Cell 2001 105 6 721 732 (Pubitemid 32635102)
12. Cross D. A. E., Alessi D. R., Cohen P., Andjelkovich M., Hemmings B. A., Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 1995 378 6559 785 789 (Pubitemid 26004411)
13. Eldar-Finkelman H., Seger R., Vandenheede J. R., Krebs E. G., Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells Journal of Biological Chemistry 1995 270 3 987 990
14. Kim L., Liu J., Kimmel A. R., The novel tyrosine kinase ZAK1 activates GSK3 to direct cell fate specification Cell 1999 99 4 399 408
15. Bhat R. V., Budd Haeberlein S. L., Avila J., Glycogen synthase kinase 3: a drug target for CNS therapies Journal of Neurochemistry 2004 89 6 1313 1317 (Pubitemid 38802652)
16. Hernndez F., Pérez M., Lucas J. J., Mata A. M., Bhat R., Avila J., Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35: implications for Alzheimer's disease Journal of Biological Chemistry 2004 279 5 3801 3806 (Pubitemid 38140625)
17. Fulga T. A., Elson-Schwab I., Khurana V., Steinhilb M. L., Spires T. L., Hyman B. T., Feany M. B., Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo Nature Cell Biology 2007 9 2 139 148 (Pubitemid 46420856)
18. Cohen P., Goedert M., GSK3 inhibitors: development and therapeutic potential Nature Reviews Drug Discovery 2004 3 6 479 487 (Pubitemid 38807530)
19. Emamian E. S., Hall D., Birnbaum M. J., Karayiorgou M., Gogos J. A., Convergent evidence for impaired AKT1-GSK3 signaling in schizophrenia Nature Genetics 2004 36 2 131 137 (Pubitemid 38174370)
20. Beaulieu J. M., Sotnikova T. D., Yao W. D., Kockeritz L., Woodgett J. R., Gainetdinov R. R., Caron M. G., Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade Proceedings of the National Academy of Sciences of the United States of America 2004 101 14 5099 5104 (Pubitemid 38469209)
21. Klein P. S., Melton D. A., A molecular mechanism for the effect of lithium on development Proceedings of the National Academy of Sciences of the United States of America 1996 93 16 8455 8459 (Pubitemid 26269579)
22. Kozikowski A. P., Gaisina I. N., Petukhov P. A., Sridhar J., King L. T., Blond S. Y., Duka T., Rusnak M., Sidhu A., Highly potent and specific GSK-3 inhibitors that block tau phosphorylation and decrease -synuclein protein expression in a cellular model of Parkinson's disease ChemMedChem 2006 1 2 256 266 (Pubitemid 43700306)
23. Wang L., Lin H. K., Hu Y. C., Xie S., Yang L., Chang C., Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 in prostate cells Journal of Biological Chemistry 2004 279 31 32444 32452 (Pubitemid 39014699)
24. Shakoori A., Ougolkov A., Zhi W. Y., Zhang B., Modarressi M. H., Billadeau D. D., Mai M., Takahashi Y., Minamoto T., Deregulated GSK3 activity in colorectal cancer: its association with tumor cell survival and proliferation Biochemical and Biophysical Research Communications 2005 334 4 1365 1373 (Pubitemid 41074725)
25. Shakoori A., Mai W., Miyashita K., Yasumoto K., Takahashi Y., Ooi A., Kawakami K., Minamoto T., Inhibition of GSK-3 activity attenuates proliferation of human colon cancer cells in rodents Cancer Science 2007 98 9 1388 1393 (Pubitemid 47241761)
26. Ougolkov A. V., Fernandez-Zapico M. E., Savoy D. N., Urrutia R. A., Billadeau D. D., Glycogen synthase kinase-3 participates in nuclear factor B-mediated gene transcription and cell survival in pancreatic cancer cells Cancer Research 2005 65 6 2076 2081 (Pubitemid 40490111)
27. Beurel E., Jope R. S., The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways Progress in Neurobiology 2006 79 4 173 189 (Pubitemid 44331500)
28. Miller J. R., Moon R. T., Signal transduction through -catenin and specification of cell fate during embryogenesis Genes and Development 1996 10 20 2527 2539 (Pubitemid 26357220)
29. Peifer M., Polakis P., Wnt signaling in oncogenesis and embryogenesisa look outside the nucleus Science 2000 287 5458 1606 1609 (Pubitemid 30127755)
30. Giles R. H., Van Es J. H., Clevers H., Caught up in a Wnt storm: Wnt signaling in cancer Biochimica et Biophysica Acta 2003 1653 1 1 24 (Pubitemid 36627817)
31. Diehl J. A., Cheng M., Roussel M. F., Sherr C. J., Glycogen synthase kinase-3 regulates cyclin D1 proteolysis and subcellular localization Genes and Development 1998 12 22 3499 3511 (Pubitemid 28553242)
32. Bijur G. N., De Sarno P., Jope R. S., Glycogen synthase kinase-3 facilitates staurosporine- and heat shock- induced apoptosis. Protection by lithium Journal of Biological Chemistry 2000 275 11 7583 7590 (Pubitemid 30159657)
33. Forde J. E., Dale T. C., Glycogen synthase kinase 3: a key regulator of cellular fate Cellular and Molecular Life Sciences 2007 64 15 1930 1944 (Pubitemid 47094432)
34. Watcharasit P., Bijur G. N., Zmijewski J. W., Song L., Zmijewska A., Chen X., Johnson G. V. W., Jope R. S., Direct, activating interaction between glycogen synthase kinase-3 and p53 after DNA damage Proceedings of the National Academy of Sciences of the United States of America 2002 99 12 7951 7955 (Pubitemid 34650986)
35. Loberg R. D., Vesely E., Brosius F. C., Enhanced glycogen synthase kinase-3 activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism Journal of Biological Chemistry 2002 277 44 41667 41673 (Pubitemid 35257473)
36. Song L., De Sarno P., Jope R. S., Central role of glycogen synthase kinase-3 in endoplasmic reticulum stress-induced caspase-3 activation Journal of Biological Chemistry 2002 277 47 44701 44708 (Pubitemid 36159060)
37. Carmichael J., Sugars K. L., Bao Y. P., Rubinsztein D. C., Glycogen synthase kinase-3 inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation Journal of Biological Chemistry 2002 277 37 33791 33798
38. Cross D. A. E., Culbert A. A., Chalmers K. A., Facci L., Skaper S. D., Reith A. D., Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death Journal of Neurochemistry 2001 77 1 94 102 (Pubitemid 32245083)
39. Yazlovitskaya E. M., Edwards E., Thotala D., Fu A., Osusky K. L., Whetsell W. O., Boone B., Shinohara E. T., Hallahan D. E., Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation Cancer Research 2006 66 23 11179 11186 (Pubitemid 46009945)
40. Culbert A. A., Brown M. J., Frame S., Hagen T., Cross D. A. E., Bax B., Reith A. D., GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and -catenin stabilisation without elevation of glycogen synthase activity FEBS Letters 2001 507 3 288 294 (Pubitemid 33030251)
41. Bijur G. N., De Sarno P., Jope R. S., Glycogen synthase kinase-3 facilitates staurosporine- and heat shock- induced apoptosis. Protection by lithium Journal of Biological Chemistry 2000 275 11 7583 7590 (Pubitemid 30159657)
42. Grimes C. A., Jope R. S., The multifaceted roles of glycogen synthase kinase 3 in cellular signaling Progress in Neurobiology 2001 65 4 391 426 (Pubitemid 32781670)
43. Oren M., Decision making by p53: life, death and cancer Cell Death and Differentiation 2003 10 4 431 442 (Pubitemid 36626355)
44. Kruse J. P., Gu W., Modes of p53 Regulation Cell 2009 137 4 609 622
45. Watcharasit P., Bijur G. N., Song L., Zhu J., Chen X., Jope R. S., Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53 The Journal of Biological Chemistry 2003 278 49 48872 48879
46. Beurel E., Kornprobst M., Blivet-Van Eggelpol M. J., Ruiz-Ruiz C., Cadoret A., Capeau J., Desbois-Mouthon C., GSK-3 inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression Experimental Cell Research 2004 300 2 354 364 (Pubitemid 39314425)
47. Turenne G. A., Price B. D., Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity BMC Cell Biology 2001 2
48. Pluquet O., Qu L. K., Baltzis D., Koromilas A. E., Endoplasmic reticulum stress accelerates p53 degradation by the cooperative actions of Hdm2 and glycogen synthase kinase 3 Molecular and Cellular Biology 2005 25 21 9392 9405 (Pubitemid 41507840)
49. Qu L., Huang S., Baltzis D., Rivas-Estilla A. M., Pluquet O., Hatzoglou M., Koumenis C., Taya Y., Yoshimura A., Koromilas A. E., Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3 Genes and Development 2004 18 3 261 277 (Pubitemid 38199252)
50. Eom T. Y., Roth K. A., Jope R. S., Neural precursor cells are protected from apoptosis induced by trophic factor withdrawal or genotoxic stress by inhibitors of glycogen synthase kinase 3 Journal of Biological Chemistry 2007 282 31 22856 22864 (Pubitemid 47267357)
51. Arboleda G., Cardenas Y., Rodriguez Y., Morales L. C., Matheus L., Arboleda H., Differential regulation of AKT, MAPK and GSK3beta during C2-ceramide-induced neuronal death Neurotoxicology 2010 31 6 687 693
52. Mora A., Sabio G., Risco A. M., Cuenda A., Alonso J. C., Soler G., Centeno F., Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A Cellular Signalling 2002 14 6 557 562 (Pubitemid 34230591)
53. Noh K. T., Park Y. M., Cho S. G., Choi E. J., GSK-3 -induced ASK1 stabilization is crucial in LPS-induced endotoxin shock Experimental Cell Research 2011 317 12 1663 1668
54. Sengupta S., Jayaraman P., Chilton P. M., Casella C. R., Mitchell T. C., Unrestrained glycogen synthase kinase-3 activity leads to activated T cell death and can be inhibited by natural adjuvant Journal of Immunology 2007 178 10 6083 6091 (Pubitemid 46717388)
55. Kang Y. J., Digicaylioglu M., Russo R., Kaul M., Achim C. L., Fletcher L., Masliah E., Lipton S. A., Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders Annals of Neurology 2010 68 3 342 352
56. Peng F., Dhillon N. K., Yao H., Zhu X., Williams R., Buch S., Mechanisms of platelet-derived growth factor-mediated neuroprotectionimplications in HIV dementia European Journal of Neuroscience 2008 28 7 1255 1264
57. Sui Z., Sniderhan L. F., Fan S., Kazmierczak K., Reisinger E., Kovcs A. D., Potash M. J., Dewhurst S., Gelbard H. A., Maggirwar S. B., Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3 to antagonize nuclear factor- B survival pathway in neurons European Journal of Neuroscience 2006 23 10 2623 2634 (Pubitemid 43801454)
58. Goldbaum O., Richter-Landsberg C., Activation of PP2A-like phosphatase and modulation of tau phosphorylation accompany stress-induced apoptosis in cultured oligodendrocytes GLIA 2002 40 3 271 282 (Pubitemid 36016722)
59. Kihira T., Suzuki A., Kondo T., Wakayama I., Yoshida S., Hasegawa K., Garruto R. M., Immunohistochemical expression of IGF-I and GSK in the spinal cord of Kii and Guamanian ALS patients: original Article Neuropathology 2009 29 5 548 558
60. Koh S. H., Lee Y. B., Kim K. S., Kim H. J., Kim M., Lee Y. J., Kim J., Lee K. W., Kim S. H., Role of GSK-3 activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene European Journal of Neuroscience 2005 22 2 301 309 (Pubitemid 41097603)
61. Liang M. H., Wendland J. R., Chuang D. M., Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling Molecular and Cellular Neuroscience 2008 37 3 440 453
62. Martins D. F., Rosa A. O., Gadotti V. M., Mazzardo-Martins L., Nascimento F. P., Egea J., Lpez M. G., Santos A. R. S., The antinociceptive effects of AR-A014418, a selective inhibitor of glycogen synthase kinase-3 beta, in mice Journal of Pain 2011 12 3 315 322
63. Pérez M., Rojo A. I., Wandosell F., Daz-Nido J., Avila J., Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3 Biochemical Journal 2003 372 1 129 136 (Pubitemid 36609614)
64. Tang Z., Arjunan P., Lee C., Li Y., Kumar A., Hou X., Wang B., Wardega P., Zhang F., Dong L., Zhang Y., Zhang S. Z., Ding H., Fariss R. N., Becker K. G., Lennartsson J., Nagai N., Cao Y., Li X., Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3 phosphorylation Journal of Experimental Medicine 2010 207 4 867 880
65. Gall J. M., Wong V., Pimental D. R., Havasi A., Wang Z., Pastorino J. G., Bonegio R. G. B., Schwartz J. H., Borkan S. C., Hexokinase regulates Bax-mediated mitochondrial membrane injury following ischemic stress Kidney International 2011 79 11 1207 1216
66. Hotokezaka Y., van Leyen K., Lo E. H., Beatrix B., Katayama I., Jin G., Nakamura T., AlphaNAC depletion as an initiator of ER stress-induced apoptosis in hypoxia Cell Death Differentiation 2009 16 11 1505 1514
67. Li Q., Li H., Roughton K., Wang X., Kroemer G., Blomgren K., Zhu C., Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia Cell Death and Disease 2010 1 7, article e56
68. Vasileva A. K., Plotnikov E. Y., Kazachenko A. V., Kirpatovsky V. I., Zorov D. B., Inhibition of GSK-3 decreases the ischemia-induced death of renal cells Bulletin of Experimental Biology and Medicine 2010 149 3 303 307
69. Kulikov R., Boehme K. A., Blattner C., Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance Molecular and Cellular Biology 2005 25 16 7170 7180 (Pubitemid 41105913)
70. Thotala D. K., Hallahan D. E., Yazlovitskaya E. M., Inhibition of glycogen synthase kinase 3 attenuates neurocognitive dysfunction resulting from cranial irradiation Cancer Research 2008 68 14 5859 5868
71. Thotala D. K., Hallahan D. E., Yazlovitskaya E. M., Glycogen synthase kinase 3 inhibitors protect hippocampal neurons from radiation-induced apoptosis by regulating MDM2-p53 pathway Cell Death and Differentiation 2011 19 387 396
72. Lu R., Song L., Jope R. S., Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells NeuroReport 1999 10 5 1123 1125 (Pubitemid 29318000)
73. Zmijewski J. W., Jope R. S., Nuclear accumulation of glycogen synthase kinase-3 during replicative senescence of human fibroblasts Aging Cell 2004 3 5 309 317 (Pubitemid 40246699)
74. Youle R. J., Strasser A., The BCL-2 protein family: opposing activities that mediate cell death Nature Reviews Molecular Cell Biology 2008 9 1 47 59
75. Lessene G., Czabotar P. E., Colman P. M., BCL-2 family antagonists for cancer therapy Nature Reviews Drug Discovery 2008 7 12 989 1000
76. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., Wang X., Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade Cell 1997 91 4 479 489 (Pubitemid 27508237)
77. Thotala D. K., Geng L., Dickey A. K., Hallahan D. E., Yazlovitskaya E. M., A New class of molecular targeted radioprotectors: GSK-3 inhibitors International Journal of Radiation Oncology Biology Physics 2010 76 2 557 565
78. Datta S. R., Brunet A., Greenberg M. E., Cellular survival: a play in three akts Genes and Development 1999 13 22 2905 2927
79. Dickey A., Schleicher S., Leahy K., Hu R., Hallahan D., Thotala D. K., GSK-3 inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line Journal of Neuro-Oncology 2010 104 145 153
80. Meares G. P., Jope R. S., Resolution of the nuclear localization mechanism of glycogen synthase kinase-3: functional effects in apoptosis Journal of Biological Chemistry 2007 282 23 16989 17001 (Pubitemid 47093248)
81. Korur S., Huber R. M., Sivasankaran B., Petrich M., Morin P., Hemmings B. A., Merlo A., Lino M. M., GSK3beta regulates differentiation and growth arrest in glioblastoma PloS One 2009 4 10, article e7443
82. Kotliarova S., Pastorino S., Kovell L. C., Kotliarov Y., Song H., Zhang W., Bailey R., Maric D., Zenklusen J. C., Lee J., Fine H. A., Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor- B, and glucose regulation Cancer Research 2008 68 16 6643 6651
83. Sun M., Song L., Li Y., Zhou T., Jope R. S., Identification of an antiapoptotic protein complex at death receptors Cell Death and Differentiation 2008 15 12 1887 1900
84. Ven R., Larghero P., Arena G., Sporn M. B., Albini A., Tosetti F., Glycogen synthase kinase 3 regulates cell death induced by synthetic triterpenoids Cancer Research 2008 68 17 6987 6996
85. Damalas A., Ben-Ze'ev A., Simcha I., Shtutman M., Martinez Leal J. F., Zhurinsky J., Geiger B., Oren M., Excess -catenin promotes accumulation of transcriptionally active p53 EMBO Journal 1999 18 11 3054 3063 (Pubitemid 29255614)
86. Sadot E., Geiger B., Oren M., Ben-Ze'ev A., Down-regulation of -catenin by activated p53 Molecular and Cellular Biology 2001 21 20 6768 6781
87. Meares G. P., Mines M. A., Beurel E., Eom T. Y., Song L., Zmijewska A. A., Jope R. S., Glycogen synthase kinase-3 regulates endoplasmic reticulum (ER) stress-induced CHOP expression in neuronal cells Experimental Cell Research 2011 317 11 1621 1628
88. Hoeflich K. P., Luo J., Rubie E. A., Tsao M. S., Jin O., Woodgett J. R., Requirement for glycogen synthase kinase-3 in cell survival and NF- B activation Nature 2000 406 6791 86 90 (Pubitemid 30460216)
89. Demarchi F., Bertoli C., Sandy P., Schneider C., Glycogen synthase kinase-3 regulates NF- B1/p105 stability Journal of Biological Chemistry 2003 278 41 39583 39590 (Pubitemid 37258323)
90. Schwabe R. F., Brenner D. A., Role of glycogen synthase kinase-3 in TNF- -induced NF- B activation and apoptosis in hepatocytes American Journal of Physiology 2002 283 1 G204 G211
91. Deng J., Miller S. A., Wang H. Y., Xia W., Wen Y., Zhou B. P., Li Y., Lin S. Y., Hung M. C., -catenin interacts with and inhibits NF- B in human colon and breast cancer Cancer Cell 2002 2 4 323 334 (Pubitemid 41043966)
92. Gotschel F., Kern C., Lang S., Sparna T., Markmann C., Schwager J., McNelly S., von Weizsacker F., Laufer S., Hecht A., Inhibition of GSK3 differentially modulates NF-kappaB, CREB, AP-1 and beta-catenin signaling in hepatocytes, but fails to promote TNF-alpha-induced apoptosis Experimental Cell Research 2008 314 6 1351 1366
93. Schotte P., Van Loo G., Carpentier I., Vandenabeele P., Beyaert R., Lithium sensitizes tumor cells in an NF B-independent way to caspase activation and apoptosis induced by tumor necrosis factor (TNF): evidence for a role of the TNF receptor-associated death domain protein Journal of Biological Chemistry 2001 276 28 25939 25945
94. Liao X., Zhang L., Thrasher J. B., Du J., Li B., Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer. Molecular Cancer Therapeutics 2003 2 11 1215 1222
95. Bijur G. N., Jope R. S., Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 Journal of Biological Chemistry 2001 276 40 37436 37442
96. Takahashi-Yanaga F., Sasaguri T., GSK-3 regulates cyclin D1 expression: a new target for chemotherapy Cellular Signalling 2008 20 4 581 589 (Pubitemid 351241128)
97. Arcaro A., Wymann M. P., Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses Biochemical Journal 1993 296 2 297 301 (Pubitemid 23350826)
98. Pap M., Cooper G. M., Role of glycogen synthase kinase-3 in the phosphatidylinositol 3- kinase/Akt cell survival pathway Journal of Biological Chemistry 1998 273 32 19929 19932 (Pubitemid 28377539)
99. Vlahos C. J., Matter W. F., Hui K. Y., Brown R. F., A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)- 8-phenyl-4H-1-benzopyran-4- one (LY294002) Journal of Biological Chemistry 1994 269 7 5241 5248
100. Arico S., Pattingre S., Bauvy C., Gane P., Barbat A., Codogno P., Ogier-Denis E., Celecoxib induces apoptosis by inhibiting 3-phosphoinositide- dependent protein kinase-1 activity in the human colon cancer HT-29 cell line Journal of Biological Chemistry 2002 277 31 27613 27621 (Pubitemid 34966703)
101. Hill M. M., Andjelkovic M., Brazil D. P., Ferrari S., Fabbro D., Hemmings B. A., Insulin-stimulated protein kinase B phosphorylation on Ser-473 is independent of its activity and occurs through a staurosporine-insensitive kinase Journal of Biological Chemistry 2001 276 28 25643 25646
102. Hussain A. R., Al-Rasheed M., Manogaran P. S., Al-Hussein K. A., Platanias L. C., Al Kuraya K., Uddin S., Curcumin induces apoptosis via inhibition of PI3′;-kinase/AKT pathway in acute T cell leukemias Apoptosis 2006 11 2 245 254 (Pubitemid 43291024)
103. Meggio F., Donella Deana A., Ruzzene M., Brunati A. M., Cesaro L., Guerra B., Meyer T., Mett H., Fabbro D., Furet P., Dobrowolska G., Pinna L. A., Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2 European Journal of Biochemistry 1995 234 1 317 322
104. Nol A., Barrier L., Rinaldi F., Hubert C., Fauconneau B., Ingrand S., Lithium chloride and staurosporine potentiate the accumulation of phosphorylated glycogen synthase kinase 3 /Tyr216, resulting in glycogen synthase kinase 3 activation in SH-SY5Y human neuroblastoma cell lines Journal of Neuroscience Research 2011 89 5 755 763
105. Alao J. P., Stavropoulou A. V., Lam E. W. F., Coombes R. C., Role of glycogen synthase kinase 3 beta (GSK3 ) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells Molecular Cancer 2006 5, article 40
106. Yang L., Dan H. C., Sun M., Liu Q., Sun X. M., Feldman R. I., Hamilton A. D., Polokoff M., Nicosia S. V., Herlyn M., Sebti S. M., Cheng J. Q., Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt Cancer Research 2004 64 13 4394 4399 (Pubitemid 38856907)
107. Dong J., Peng J., Zhang H., Mondesire W. H., Jian W., Mills G. B., Hung M. C., Meric-Bernstam F., Role of glycogen synthase kinase 3 in rapamycin-mediated cell cycle regulation and chemosensitivity Cancer Research 2005 65 5 1961 1972 (Pubitemid 40478626)
108. Zhang H. H., Lipovsky A. I., Dibble C. C., Sahin M., Manning B. D., S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt Molecular Cell 2006 24 2 185 197 (Pubitemid 44574477)
109. Benkoussa M., Brand C., Delmotte M. H., Formstecher P., Lefebvre P., Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter Molecular and Cellular Biology 2002 22 13 4522 4534 (Pubitemid 34620390)
110. Ma Y., Feng Q., Sekula D., Diehl J. A., Freemantle S. J., Dmitrovsky E., Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms Cancer Research 2005 65 14 6476 6483 (Pubitemid 40994437)
111. Mori J., Takahashi-Yanaga F., Miwa Y., Watanabe Y., Hirata M., Morimoto S., Shirasuna K., Sasaguri T., Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma Experimental Cell Research 2005 310 2 426 433 (Pubitemid 41457345)
112. Takahashi-Yanaga F., Taba Y., Miwa Y., Kubohara Y., Watanabe Y., Hirata M., Morimoto S., Sasaguri T., Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3 and degrades cyclin D1 in mammalian cells Journal of Biological Chemistry 2003 278 11 9663 9670 (Pubitemid 36800463)
113. Medina M., Avila J., Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer's disease Current Pharmaceutical Design 2010 16 25 2790 2798
114. Avila J., Hernndez F., GSK-3 inhibitors for Alzheimer's disease Expert Review of Neurotherapeutics 2007 7 11 1527 1533 (Pubitemid 350106832)
115. Klamer G., Song E., Ko K. H., O'Brien T. A., Dolnikov A., Using small molecule GSK3 inhibitors to treat inflammation Current Medicinal Chemistry 2010 17 26 2873 2881
116. Phukan S., Babu V. S., Kannoji A., Hariharan R., Balaji V. N., GSK3 : role in therapeutic landscape and development of modulators British Journal of Pharmacology 2010 160 1 1 19
117. Ryves W. J., Dajani R., Pearl L., Harwood A. J., Glycogen synthase kinase-3 inhibition by lithium and beryllium suggests the presence of two magnesium binding sites Biochemical and Biophysical Research Communications 2002 290 3 967 972 (Pubitemid 34687456)
118. Martinez A., Castro A., Dorronsoro I., Alonso M., Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation Medicinal Research Reviews 2002 22 4 373 384 (Pubitemid 34620473)
119. Aoki M., Yokota T., Sugiura I., Sasaki C., Hasegawa T., Okumura C., Ishiguro K., Kohno T., Sugio S., Matsuzaki T., Structural insight into nucleotide recognition in tau-protein kinase I/glycogen synthase kinase 3 Acta Crystallographica D 2004 60 3 439 446 (Pubitemid 41087571)
120. Bax B., Carter P. S., Lewis C., Guy A. R., Bridges A., Tanner R., Pettman G., Mannix C., Culbert A. A., Brown M. J. B., Smith D. G., Reith A. D., The structure of phosphorylated GSK-3 complexed with a peptide, FRATtide, that inhibits -catenin phosphorylation Structure 2001 9 12 1143 1152 (Pubitemid 34025049)
121. Bertrand J. A., Thieffine S., Vulpetti A., Cristiani C., Valsasina B., Knapp S., Kalisz H. M., Flocco M., Structural characterization of the GSK-3 active site using selective and non-selective ATP-mimetic inhibitors Journal of Molecular Biology 2003 333 2 393 407 (Pubitemid 37188580)
122. Bhat R., Xue Y., Berg S., Hellberg S., Ormo M., Nilsson Y., Radesater A. C., Jerning E., Markgren P. O., Borgegard T., Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418 The Journal of Biological Chemistry 2003 278 46 45937 45945 (Pubitemid 37432740)
123. Dajani R., Fraser E., Roe S. M., Yeo M., Good V. M., Thompson V., Dale T. C., Pearl L. H., Structural basis for recruitment of glycogen synthase kinase 3 to the axin-APC scaffold complex EMBO Journal 2003 22 3 494 501 (Pubitemid 36193594)
124. Shin D., Lee S. C., Heo Y. S., Lee W. Y., Cho Y. S., Kim Y. E., Hyun Y. L., Cho J. M., Lee Y. S., Ro S., Design and synthesis of 7-hydroxy-1H- benzoimidazole derivatives as novel inhibitors of glycogen synthase kinase-3 Bioorganic and Medicinal Chemistry Letters 2007 17 20 5686 5689 (Pubitemid 47398948)
125. Zhang H. C., Bonaga L. V., Ye H., Derian C. K., Damiano B. P., Maryanoff B. E., Novel bis(indolyl)maleimide pyridinophanes that are potent, selective inhibitors of glycogen synthase kinase-3 Bioorganic Medicinal Chemistry Letters 2007 17 10 2863 2868 (Pubitemid 46636245)
126. Jope R. S., Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes Trends in Pharmacological Sciences 2003 24 9 441 443 (Pubitemid 37088166)
127. Coghlan M. P., Culbert A. A., Cross D. A. E., Corcoran S. L., Yates J. W., Pearce N. J., Rausch O. L., Murphy G. J., Carter P. S., Roxbee Cox L., Mills D., Brown M. J., Haigh D., Ward R. W., Smith D. G., Murray K. J., Reith A. D., Holder J. C., Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription Chemistry and Biology 2000 7 10 793 803
128. Meijer L., Thunnissen A. M. W. H., White A. W., Garnier M., Nikolic M., Tsai L. H., Walter J., Cleverley K. E., Salinas P. C., Wu Y. Z., Biernat J., Mandelkow E. M., Kim S. H., Pettit G. R., Inhibition of cyclin-dependent kinases, GSK-3 and CK1 by hymenialdisine, a marine sponge constituent Chemistry and Biology 2000 7 1 51 63 (Pubitemid 30141925)
129. Zaharevitz D. W., Gussio R., Leost M., Senderowicz A. M., Lahusen T., Kunick C., Meijer L., Sausville E. A., Discovery and initial characterization of the paullones, a novel class of smallmolecule inhibitors of cyclin-dependent kinases Cancer Research 1999 59 11 2566 2569 (Pubitemid 29269099)
130. Hoessel R., Leclerc S., Endicott J. A., Nobel M. E. M., Lawrie A., Tunnah P., Leost M., Damiens E., Marie D., Marko D., Niederberger E., Tang W., Eisenbrand G., Meijer L., Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases Nature Cell Biology 1999 1 1 60 67 (Pubitemid 129495012)
131. Leclerc S., Garnier M., Hoessel R., Marko D., Bibb J. A., Snyder G. L., Greengard P., Biernat J., Wu Y. Z., Mandelkow E. M., Eisenbrand G., Meijert L., Indirubins inhibit glycogen synthase kinase-3 and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? Journal of Biological Chemistry 2001 276 1 251 260 (Pubitemid 32050314)
132. Meijer L., Skaltsounis A. L., Magiatis P., Polychronopoulos P., Knockaert M., Leost M., Ryan X. P., Vonica C. A., Brivanlou A., Dajani R., Crovace C., Tarricone C., Musacchio A., Roe S. M., Pearl L., Greengard P., GSK-3-selective inhibitors derived from tyrian purple indirubins Chemistry and Biology 2003 10 12 1255 1266 (Pubitemid 38050973)
133. Martinez A., Alonso M., Castro A., Pérez C., Moreno F. J., First non-ATP competitive glycogen synthase kinase 3 (GSK-3 ) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease Journal of Medicinal Chemistry 2002 45 6 1292 1299 (Pubitemid 34263565)
134. Coghlan M. P., Culbert A. A., Cross D. A. E., Corcoran S. L., Yates J.
135. Thomas G. M., Frame S., Goedert M., Nathke I., Polakis P., Cohen P., A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of Axin and -catenin FEBS Letters 1999 458 2 247 251 (Pubitemid 29428192)